Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class
Equity / Common Stock, par value $0.0001
Total 13F shares
21,243,183
Total 13F value
$277,395,506
Holder snapshot 6 signals
Share change
+2,165,286
SEC-reported price per share
$13.01
Number of holders
37
Value change
+$28,289,371
Number of buys
25
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,393,481

Security key

08205P209

Report period

Q1 2025

Institutions

37

Top holders

10

BNTC full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2025 Previous quarter: Q4 2024 Benitec Biopharma Inc. SEC filings Benitec Biopharma Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 13F Lead comparable stake: 4.5% 13D/G row: HBM Healthcare Investments (Cayman) Ltd. Showing 1-6 of 15 holder rows.

Quick read

HBM Healthcare Investments (Cayman) Ltd. leads the comparable SEC ownership view at 4.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HBM Healthcare Investments (Cayman) Ltd.'s linked filing trail.
Comparable ownership Top 5
HBM Healthcare Investments (Cayma... 4.5%
Nantahala Capital Management, LLC 4.4%
SUVRETTA CAPITAL MANAGEMENT, LLC 25%
FRANKLIN RESOURCES INC 8.3%
JANUS HENDERSON GROUP PLC 7.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HBM Healthcare Investments (Cayman) Ltd.
13D/G
13D/G
4.5%
$14,156,282
1,041,669 shares
 $0 31 Dec 2024
Nantahala Capital Management, LLC
13D/G 13F
Company
13D/G 13F
4.4%
$14,111,462
1,038,371 shares
 $0 31 Mar 2025
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
25%
$113,164,914
8,960,009 shares
 — 31 Dec 2024
FRANKLIN RESOURCES INC
13F
Company
13F
8.3%
$37,123,195
2,939,287 shares
 — 31 Dec 2024
JANUS HENDERSON GROUP PLC
13F
Company
13F
7.4%
$33,267,869
2,616,427 shares
 — 31 Dec 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
5.6%
$24,912,978
1,972,524 shares
 — 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
37
Shares
21,243,183
Rows available
37
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
30
Q1 2025 holders
37
Holder diff
7
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .